| NOVARTIS | INTEGRA ESSENTIA | NOVARTIS/ INTEGRA ESSENTIA |
|||
|---|---|---|---|---|---|
| P/E (TTM) | x | 40.4 | -1,269.4 | - | View Chart |
| P/BV | x | 5.0 | 1.3 | 380.0% | View Chart |
| Dividend Yield | % | 1.6 | 0.0 | - |
NOVARTIS INTEGRA ESSENTIA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| NOVARTIS Mar-25 |
INTEGRA ESSENTIA Mar-25 |
NOVARTIS/ INTEGRA ESSENTIA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 1,248 | 5 | 23,771.4% | |
| Low | Rs | 745 | 2 | 35,473.8% | |
| Sales per share (Unadj.) | Rs | 144.3 | 4.1 | 3,487.8% | |
| Earnings per share (Unadj.) | Rs | 40.9 | 0 | 113,657.2% | |
| Cash flow per share (Unadj.) | Rs | 41.8 | 0.1 | 57,948.9% | |
| Dividends per share (Unadj.) | Rs | 25.00 | 0 | - | |
| Avg Dividend yield | % | 2.5 | 0 | - | |
| Book value per share (Unadj.) | Rs | 317.9 | 1.6 | 20,007.8% | |
| Shares outstanding (eoy) | m | 24.69 | 1,067.69 | 2.3% | |
| Bonus / Rights / Conversions | 0 | 0 | - | ||
| Price / Sales ratio | x | 6.9 | 0.9 | 777.5% | |
| Avg P/E ratio | x | 24.4 | 102.2 | 23.9% | |
| P/CF ratio (eoy) | x | 23.9 | 51.0 | 46.8% | |
| Price / Book Value ratio | x | 3.1 | 2.3 | 135.5% | |
| Dividend payout | % | 61.2 | 0 | - | |
| Avg Mkt Cap | Rs m | 24,604 | 3,924 | 627.0% | |
| No. of employees | `000 | NA | NA | - | |
| Total wages/salary | Rs m | 187 | 6 | 3,014.5% | |
| Avg. sales/employee | Rs Th | 0 | 0 | - | |
| Avg. wages/employee | Rs Th | 0 | 0 | - | |
| Avg. net profit/employee | Rs Th | 0 | 0 | - | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 3,563 | 4,417 | 80.7% | |
| Other income | Rs m | 420 | 75 | 562.5% | |
| Total revenues | Rs m | 3,982 | 4,492 | 88.7% | |
| Gross profit | Rs m | 914 | 42 | 2,179.3% | |
| Depreciation | Rs m | 22 | 39 | 56.8% | |
| Interest | Rs m | 8 | 16 | 48.8% | |
| Profit before tax | Rs m | 1,304 | 62 | 2,095.8% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 295 | 24 | 1,238.3% | |
| Profit after tax | Rs m | 1,009 | 38 | 2,628.3% | |
| Gross profit margin | % | 25.7 | 0.9 | 2,701.7% | |
| Effective tax rate | % | 22.6 | 38.3 | 59.1% | |
| Net profit margin | % | 28.3 | 0.9 | 3,258.6% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 10,299 | 1,042 | 988.4% | |
| Current liabilities | Rs m | 4,261 | 460 | 926.3% | |
| Net working cap to sales | % | 169.5 | 13.2 | 1,286.3% | |
| Current ratio | x | 2.4 | 2.3 | 106.7% | |
| Inventory Days | Days | 895 | 53 | 1,691.9% | |
| Debtors Days | Days | 41 | 557 | 7.4% | |
| Net fixed assets | Rs m | 8,780 | 1,168 | 752.0% | |
| Share capital | Rs m | 123 | 1,068 | 11.6% | |
| "Free" reserves | Rs m | 7,726 | 629 | 1,228.6% | |
| Net worth | Rs m | 7,850 | 1,697 | 462.7% | |
| Long term debt | Rs m | 0 | 43 | 0.0% | |
| Total assets | Rs m | 19,079 | 2,210 | 863.5% | |
| Interest coverage | x | 170.4 | 4.9 | 3,448.2% | |
| Debt to equity ratio | x | 0 | 0 | 0.0% | |
| Sales to assets ratio | x | 0.2 | 2.0 | 9.3% | |
| Return on assets | % | 5.3 | 2.5 | 217.3% | |
| Return on equity | % | 12.9 | 2.3 | 568.0% | |
| Return on capital | % | 16.7 | 4.5 | 372.7% | |
| Exports to sales | % | 0 | 0 | - | |
| Imports to sales | % | 0 | 0 | - | |
| Exports (fob) | Rs m | NA | NA | - | |
| Imports (cif) | Rs m | NA | NA | - | |
| Fx inflow | Rs m | 0 | 0 | - | |
| Fx outflow | Rs m | 810 | 0 | - | |
| Net fx | Rs m | -810 | 0 | - | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 746 | -914 | -81.6% | |
| From Investments | Rs m | -33 | 234 | -14.1% | |
| From Financial Activity | Rs m | -642 | 662 | -96.9% | |
| Net Cashflow | Rs m | 71 | -18 | -385.6% | |
| Indian Promoters | % | 0.0 | 9.7 | - | |
| Foreign collaborators | % | 70.7 | 0.0 | - | |
| Indian inst/Mut Fund | % | 1.5 | 0.0 | 5,033.3% | |
| FIIs | % | 0.2 | 0.0 | 533.3% | |
| ADR/GDR | % | 0.0 | 0.0 | - | |
| Free float | % | 29.3 | 90.3 | 32.5% | |
| Shareholders | 36,502 | 325,820 | 11.2% | ||
| Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON SYMPHONY MMTC PDS MULTI.
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
| Period | Novartis | INTEGRA ESSENTIA | S&P BSE HEALTHCARE |
|---|---|---|---|
| 1-Day | 0.68% | -4.48% | 0.28% |
| 1-Month | -4.34% | 10.34% | 0.97% |
| 1-Year | 71.50% | -35.03% | 14.12% |
| 3-Year CAGR | 31.43% | -23.44% | 22.28% |
| 5-Year CAGR | 14.71% | 14.09% | 14.17% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the INTEGRA ESSENTIA share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of INTEGRA ESSENTIA the stake stands at 9.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of INTEGRA ESSENTIA.
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 25.0 per share. This amounted to a Dividend Payout ratio of 61.2%.
INTEGRA ESSENTIA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of INTEGRA ESSENTIA.
For a sector overview, read our pharmaceuticals sector report.
Although the benchmark indices opened lower, they traded negative throughout the session and ultimately closed red.